Immunoscore ranges on a scale from I0-I4 and is based on digitally quantified densities of IHC-labeled CD3+ and CD8+ T cells, both in the tumor center (CT) and at the invasive margin (IM) (150, 154). This evidence concerns the gene CD8A and neoplasm.